Sapient is an end-to-end biomarker discovery partner for pharmaceutical and biotechnology sponsors. Our platform combines advanced mass spectrometry technologies that assay >11,000 molecules per biosample, computational learning, and an expansive proprietary Human Biology Database of >300,000 individuals to discover circulating biomarkers at unprecedented speed and scale – and make them actionable in optimizing drug pipelines and advancing clinical development.
By identifying biomarkers of biological processes, disease progression, and drug responsiveness, we help elucidate the pathways involved in disease, drug delivery, and the individuals that will respond to a particular intervention, rapidly delivering actionable insights to align patients, disease biology, and specific therapies.
Sapient is CLIA certified.
Sapient is located in San Diego, CA (USA) and services customers globally.